Journal article
Sutureless Valve in Repeated Aortic Valve Replacement: Results from an International Prospective Registry
M Glauber, WDT Kent, G Asimakopoulos, G Troise, JM Padrò, A Royse, JM Marnette, P Noirhomme, M Baghai, M Lewis, L Di Bacco, M Solinas, A Miceli
Innovations Technology and Techniques in Cardiothoracic and Vascular Surgery | SAGE PUBLICATIONS INC | Published : 2021
Abstract
Objective: To report early and midterm results registry of patients undergoing repeated aortic valve replacement (RAVR) with sutureless prostheses from an international prospective registry (SURE-AVR). Methods: Between March 2011 and June 2019, 69 patients underwent RAVR with self-expandable sutureless aortic bioprostheses at 22 international cardiac centers. Results: Overall mortality was 2.9% with a predicted logistic EuroSCORE II of 10.7%. Indications for RAVR were structural valve dysfunction (84.1%) and infective prosthetic endocarditis (15.9%) and were performed in patients with previously implanted bioprostheses (79.7%), mechanical valves (15.9%), and transcatheter valves (4.3%). Mini..
View full abstractGrants
Funding Acknowledgements
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The SURE-AVR registry is funded by LivaNova PLC.